Drug
Spironolactone
Spironolactone: highest development phase Post-Market, developed by Aurobindo, Gedeon Richter. 2 trial records tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Aurobindo, Gedeon Richter
Trials
| Drug | Phase | Indication |
|---|---|---|
| spironolactone NCT00524615 | Post-Market | Hypertension |
| SPIRONOLACTONE | Approved |
Latest
Follow Spironolactone on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.